Primary |
Renal Failure Chronic |
44.4% |
Hypothyroidism |
22.2% |
Hyperlipidaemia |
11.1% |
Primary Hypothyroidism |
11.1% |
Product Used For Unknown Indication |
11.1% |
|
Rhabdomyolysis |
40.0% |
Myalgia |
20.0% |
Palpitations |
20.0% |
Tachycardia |
20.0% |
|
Secondary |
Depression |
34.0% |
Personality Disorder |
34.0% |
Drug Use For Unknown Indication |
6.0% |
Product Used For Unknown Indication |
4.9% |
Rheumatoid Arthritis |
4.2% |
Suicide Attempt |
3.4% |
Drug Abuse |
2.3% |
Hypertension |
1.9% |
Goitre |
1.5% |
Hypothyroidism |
1.5% |
Mood Altered |
1.5% |
Gastritis |
1.1% |
Thyroid Operation |
1.1% |
Autoimmune Thyroiditis |
0.4% |
Cardiac Valve Disease |
0.4% |
Cardiac Valve Prosthesis User |
0.4% |
Growth Hormone Deficiency |
0.4% |
Hyperthyroidism |
0.4% |
Hyperuricaemia |
0.4% |
Hypogonadism |
0.4% |
|
Self Injurious Behaviour |
40.6% |
Tachycardia |
9.4% |
Vomiting |
6.3% |
Vomiting Projectile |
6.3% |
Abortion Spontaneous |
3.1% |
Drug Interaction |
3.1% |
Injury |
3.1% |
Malignant Melanoma |
3.1% |
Pleural Effusion |
3.1% |
Pre-eclampsia |
3.1% |
Skin Ulcer Haemorrhage |
3.1% |
Small For Dates Baby |
3.1% |
Suicide Attempt |
3.1% |
Therapeutic Agent Toxicity |
3.1% |
Urticaria |
3.1% |
Visual Acuity Reduced |
3.1% |
|
Concomitant |
Product Used For Unknown Indication |
25.5% |
Hypertension |
14.5% |
Hypothyroidism |
13.7% |
Drug Use For Unknown Indication |
5.7% |
Prophylaxis |
5.2% |
Rheumatoid Arthritis |
4.4% |
Atrial Fibrillation |
3.9% |
Osteoporosis |
3.5% |
Diabetes Mellitus |
3.2% |
Depression |
2.8% |
Thyroid Disorder |
2.5% |
Pain |
2.4% |
Multiple Myeloma |
2.3% |
Type 2 Diabetes Mellitus |
1.8% |
Breast Cancer |
1.7% |
Hypercholesterolaemia |
1.6% |
Anxiety |
1.5% |
Hepatitis C |
1.3% |
Bone Pain |
1.2% |
Chronic Hepatitis C |
1.2% |
|
Vomiting |
12.6% |
Syncope |
8.8% |
Renal Failure Acute |
7.9% |
Weight Increased |
6.6% |
Presyncope |
5.7% |
Thrombocytopenia |
5.7% |
Sopor |
5.0% |
Sepsis |
4.4% |
Vertigo |
4.4% |
Death |
4.1% |
Pulmonary Embolism |
4.1% |
Pyrexia |
4.1% |
Urticaria |
4.1% |
Renal Failure |
3.8% |
Malaise |
3.5% |
Respiratory Failure |
3.5% |
Hyponatraemia |
3.1% |
Toxic Skin Eruption |
3.1% |
Pneumonia |
2.8% |
Rash |
2.8% |
|
Interacting |
Hyperlipidaemia |
17.9% |
Hypothyroidism |
17.9% |
Renal Failure Chronic |
17.9% |
Atrial Flutter |
14.3% |
Atrial Fibrillation |
7.1% |
Chronic Obstructive Pulmonary Disease |
7.1% |
Diabetes Mellitus |
7.1% |
Cardiac Valve Prosthesis User |
3.6% |
Hypertension |
3.6% |
Hyperuricaemia |
3.6% |
|
Drug Interaction |
40.0% |
Pneumonia |
20.0% |
Skin Ulcer Haemorrhage |
20.0% |
Transaminases Increased |
20.0% |
|